Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Flexible-dose, Long-term Safety Extension Study of Lu AF11167 in Patients With Schizophrenia

NCT03929497 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT03929497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03929497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Flexible-dose, Long-term Safety Extension Study of Lu AF11167 in Patients With Schizophrenia
Lead sponsor
H. Lundbeck A/S
Phase
Phase 2
Overall status
Terminated
Start date
April 22, 2019
Completion date
September 14, 2020
Enrollment
96 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia